We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Imaging Technology Shows Little Discrepancy Between Breast Cancer, Healthy Tissues

By MedImaging International staff writers
Posted on 30 Sep 2014
Print article
A new application has been effectively evaluated that will help surgeons better differentiate cancerous breast tissue from normal tissue, thereby decreasing the likelihood for repeat operations. The tool, called DESI (desorption electrospray ionization) mass spectrometry imaging, works by converting molecules into electrically charged versions of themselves, called ions, so that they can be identified by their mass.

Up to 40% of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers from Brigham and Women’s Hospital (BWH; Boston, MA, USA) published the findings from their study online September 22, 2014, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS). By studying the mass of the ions, the contents of a tissue sample can then be identified. The tool sprays a microscopic stream of charged solvent onto the tissue surface to gather information about its molecular makeup and produces a color-coded image revealing the nature and concentration of tumor cells.

In this particular case, the researchers used DESI mass spectrometry imaging to look at the distribution and amounts of fatty acid substances, called lipids, within breast tissue and normal tissue from 61 samples obtained from 14 breast cancer patients that underwent mastectomy. A software program was used to characterize the breast cancer tumors and detect boundaries between healthy and cancerous tissue.

The researchers discovered that several fatty acids, such as oleic acid, were more abundant in breast cancer tissue compared to normal tissue. The findings were also confirmed using traditional pathology methods to assess for accuracy. “Our findings demonstrate the feasibility of classifying cancerous and normal breast tissues using DESI mass spectrometry imaging,” said Nathalie Agar, PhD, director of the surgical molecular imaging laboratory, BWH departments of neurosurgery and radiology, senior study author. “The results may help us to move forward in improving this method so that surgeons can use it to rapidly detect residual cancer tissue during breast cancer surgery, hopefully decreasing the need for multiple operations.”

Related Links:

Brigham and Women’s Hospital


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Thyroid Shield
Standard Thyroid Shield
New
Portable X-Ray Unit
AJEX240H
Dose Area Product Meter
VacuDAP

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.